This project is aimed at improvement of glioblastoma (GBM) diagnostic strategies for
discrimination of tumor progression and chemo- and radiotherapeutic treatment-related changes
in brain tissue. The study will elucidate the diagnostic value of PET imaging with use of
amyloid-β radioisotope tracer Amyvid (Florbetapir F18) for GBM. The results of the study will
provide data for development of new approach for GBM diagnostics.